What researchers published on Arthritis psoriatica
765 papers, newest first.
Showing 20 of 765
Not labelled yetDurable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.)
Not labelled yetTwo-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.Rheumatology and therapy
Megfigyeléses vizsgálatUnderstanding barriers: patient experience with immune-mediated rheumatic diseases in Brazilian public health.Advances in rheumatology (London, England)
ÁttekintésMultidomain efficacy and safety of IL-17A and IL-17A/F inhibitors versus adalimumab in biologic-naïve psoriatic arthritis: A systematic review and Meta-analysis of comparative trials.Autoimmunity reviews
Not labelled yetFoot and ankle involvement is common across the spondyloarthritis spectrum with distinct anatomical and clinical patterns: a post hoc cross-sectional analysis of the ASAS-PerSpA study.Rheumatology international
Not labelled yetExtracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study.Frontiers in immunology
Not labelled yetImpact of radiographic damage on health-related outcomes across rheumatoid arthritis, psoriatic arthritis, and hand osteoarthritis: a comparative analysis of disease burden.Clinical rheumatology
Not labelled yetImplementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study.Journal of drugs in dermatology : JDD
Not labelled yetProgression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors.Journal of drugs in dermatology : JDD
Not labelled yetBimekizumab in Psoriatic Arthritis: 12-Month Retention, Multidomain Effectiveness, and Impact of Prior Interleukin-17 Inhibition in a Real-World Cohort.Joint bone spine
Not labelled yetRisk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
EsetismertetésAdult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review.EULAR rheumatology open
EsetismertetésPsoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.Cureus
Not labelled yetResponse to correspondence on 'Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials' by Annfeldt et al.Annals of the rheumatic diseases
Not labelled yetDifficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry.Seminars in arthritis and rheumatism
Not labelled yetThe development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET).Arthritis & rheumatology (Hoboken, N.J.)
Not labelled yetIncidence and prevalence of hidradenitis suppurativa across spondyloarthritis-related diseases: cohort study using electronic health records.Frontiers in immunology
Not labelled yetReal‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.Annals of the rheumatic diseases
Not labelled yetSimplified liquid chromatography-mass spectrometry quantification of adalimumab reveals peptide interference and modestly stronger exposure-response associations than ELISA.Analytica chimica acta
Not labelled yetPredictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA).Rheumatology (Oxford, England)